Rabiee Ahmed, Salman Mohamed, Tourky Mohamed, Ameen Mahmoud, Hussein Ahmed, Salman Ahmed, Labib Safa, Soliman Ahmed Abdulkader Zaki Ali, Shaaban Hossam El-Din, GabAllah Ghada, Abouelregal Tarek
Internal Medicine Department, Kasralainy School of Medicine, Cairo University, Cairo, Egypt.
General Surgery Department, Kasralainy School of Medicine, Cairo University, Cairo, Egypt.
Int J Gen Med. 2021 Jun 10;14:2421-2425. doi: 10.2147/IJGM.S318398. eCollection 2021.
The study aimed to assess antithyroid antibodies in patients with benign thyroid masses and the effect of total thyroidectomy on the antibodies titers.
This is a retrospective work of 112 cases managed with total thyroidectomy with positive antithyroid peroxidase antibodies (TPO-Ab), anti-thyroglobulin antibodies (Tg-Ab), or both. All patients were euthyroid before surgery. Thyroid function tests and thyroid antibodies levels were measured before and 6 and 12 months after surgery.
Histopathological evaluation revealed Hashimoto thyroiditis (47.3%), colloid nodules (22.3%), and lymphocytic thyroiditis (30.4%). All patients were TPO-Ab positive, while 96 patients (85.7%) were Tg-Ab positive before surgery. There was no considerable change in TPO-Ab and Tg-Ab after surgery (p = 0.817, and p=0.560, respectively). Also, there was no significant difference between the three histopathological diagnoses in the levels of TPO-Ab (p = 0.086) or Tg-Ab (p = 0.673).
Antithyroid antibodies are not valuable markers for diagnosis or prognosis of benign thyroid diseases subjected to total thyroidectomy. We do not recommend their use beyond supporting evidence of the possibility of the autoimmune nature of the illness if other criteria are confirmed.
本研究旨在评估甲状腺良性肿块患者的抗甲状腺抗体,以及甲状腺全切除术对抗体滴度的影响。
这是一项对112例行甲状腺全切除术患者的回顾性研究,这些患者抗甲状腺过氧化物酶抗体(TPO-Ab)、抗甲状腺球蛋白抗体(Tg-Ab)呈阳性或两者均呈阳性。所有患者术前甲状腺功能正常。术前、术后6个月和12个月检测甲状腺功能及甲状腺抗体水平。
组织病理学评估显示桥本甲状腺炎(47.3%)、胶样结节(22.3%)和淋巴细胞性甲状腺炎(30.4%)。所有患者术前TPO-Ab均为阳性,96例患者(85.7%)术前Tg-Ab为阳性。术后TPO-Ab和Tg-Ab无明显变化(p分别为0.817和0.560)。此外,三种组织病理学诊断的TPO-Ab水平(p = 0.086)或Tg-Ab水平(p = 0.673)无显著差异。
抗甲状腺抗体对于接受甲状腺全切除术的甲状腺良性疾病的诊断或预后并非有价值的标志物。如果其他标准得到证实,除了支持疾病自身免疫性质可能性的证据外,我们不建议使用它们。